Ratings Generali London S.E.

Equities

0K78

IT0000062072

Market Closed - London S.E. Other stock markets 11:30:00 2024-04-29 am EDT			5-day change	1st Jan Change
22.86 ^EUR	+0.18%		+0.29%	+19.75%

Apr. 25	Price spiral in car insurance - 20 percent more expensive	DP
Apr. 24	Generali approves new EUR500 million buyback plan	AN

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

With a P/E ratio at 9.52 for the current year and 8.82 for next year, earnings multiples are highly attractive compared with competitors.
With regards to fundamentals, the enterprise value to sales ratio is at 0.89 for the current period. Therefore, the company is undervalued.
The company has a low valuation given the cash flows generated by its activity.
This company will be of major interest to investors in search of a high dividend stock.
Sales forecast by analysts have been recently revised upwards.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
The opinion of analysts covering the stock has improved over the past four months.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
GENERALI	+19.75%	37.78B	-
AXA	+15.94%	79.51B	B-
METLIFE, INC.	+8.42%	50.22B	B+
AFLAC INCORPORATED	+2.47%	48.11B	B
MANULIFE FINANCIAL CORPORATION	+10.21%	42.2B	B+
PRUDENTIAL FINANCIAL, INC.	+7.93%	39.71B	B+
SUN LIFE FINANCIAL INC.	+2.62%	30.07B	B
GREAT-WEST LIFECO INC.	-7.27%	27.56B	B-
PRUDENTIAL PLC	-16.43%	24.71B	A-
CATHAY FINANCIAL HOLDING CO., LTD.	+11.04%	21.99B	A

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes